Martine Hoogendoorn - Concepedia

Author

Martine Hoogendoorn

Also Known As

Hoogendoorn, Hoogendoorn M, Hoogendoorn, M., Hoogendoorn, M.N., M Hoogendoorn, M. Hoogendoorn, M. N. Hoogendoorn, Martine Hoogendoorn, Mels Hoogendoorn, P. T. P. W. Burgers

105

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam Erasmus MC National Institute for Public Health and the Environment University of Glasgow University Medical Center Groningen

About

Martine Hoogendoorn is an author at Erasmus University Rotterdam specializing in public health, health policy, and health economics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Public Health	8	8	268
2	Medicine	5	5	239
3	Engineering	1	1	18
4	Health Sciences	1	1	28
5	Computer Science	1	1	18

Martine Hoogendoorn

Publications

Citations

H-Index

Page 1

	Year	Citations
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation Martijn A. Spruit, Sally Singh, Chris Garvey, American Journal of Respiratory and Critical Care Medicine	2013	3.7K
Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial C.R. van Wetering, Martine Hoogendoorn, S. Mol, Thorax	2009	183
Efficacy and Costs of Nutritional Rehabilitation in Muscle-Wasted Patients With Chronic Obstructive Pulmonary Disease in a Community-Based Setting: A Prespecified Subgroup Analysis of the INTERCOM Trial Carel R. van Wetering, Martine Hoogendoorn, R. Broekhuizen, Journal of the American Medical Directors Association Disease ManagementChronic Disease ManagementHealth EconomicsIntercom TrialOutcomes Research	2010	132
A dynamic population model of disease progression in COPD Martine Hoogendoorn, Maureen Rutten‐van Mölken, Rudolf T. Hoogenveen, European Respiratory Journal	2005	126
Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Martine Hoogendoorn, C.R. van Wetering, Annemie M.W.J. Schols, European Respiratory Journal	2009	80
Projecting the COPD population and costs in England and Scotland: 2011 to 2030 Susannah McLean, Martine Hoogendoorn, Rudolf T. Hoogenveen, Scientific Reports	2016	76
Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice Martine Hoogendoorn, Talitha Feenstra, Tjard Schermer, Respiratory Medicine EpidemiologyPulmonary CareClinical EpidemiologyDutch General PracticeSeverity Distribution	2005	75
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands Martine Hoogendoorn, Paco M J Welsing, Maureen Rutten‐van Mölken Current Medical Research and Opinion	2007	74
Guidelines for multi-model comparisons of the impact of infectious disease interventions Saskia den Boon, Mark Jit, Marc Brisson, BMC Medicine	2019	71
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios Martine Hoogendoorn, Talitha Feenstra, Yumi Asukai, Value in Health Health EconomicsHealth PolicyCost-effectiveness ModelsOutcomes ResearchPharmacoeconomics	2014	50

Page 1